As well as bringing capacity, the investment into the new Sanofi research and vaccine facility will be used to produce the potential vaccine candidate that Sanofi are developing with GSK. Find out more for yourself
Imperial College London have recently formed a new enterprise with VacEquity Global Health in an attempt to bring their COVID-19 vaccine to the market. If successful, the vaccine will be ready for distribution by early next year. Find out more! #SupportScience #BakerScience
What do you miss about your lab? For the Stemthusiast cell culture is a massive part of her time spent in the laboratory and this week she has definitely been communicating her excitement for getting back into the lab again. Find out more today #SupportScience #BakerScience
Baker’s made-to-order approach leverages fully integrated production facilities with state-of-the-art technology, built to the highest standard. Find out more about our mission to design and develop laboratory equipment to meet your specific needs!
After entering into a multi-year research agreement with the hope of discovering up to nine antibodies, AbCellera nEli Lilly and Company are aiming for the rapid identification and creation of a possible prevention and treatment of COVID-19. Read more here! #SupportScience #BakerScience
With such an unprecedented and uncertain time, it has become apparent that the general public have substantial concerns regarding mental health. According to new research, there is currently an urgent need to tackle the harmful impacts of the COVID-19 on our mental health.
RESIPHER devices utilize proprietary high-resolution micro oxygen sensors to characterize oxygen consumption and the oxygen environment in cell culture. The RESIPHER is a handheld device that rests on top of a plate in the incubator or workstation.
Sign up to our monthly newsletter to stay up to date on everything that’s going on at Baker.